Wiley, IQVIA release healthcare AI report

While AI drastically accelerates early-stage drug discovery, the real bottleneck is the healthcare system's inability to integrate and absorb these advancements.

* Decision-first discovery will shift wet labs toward validating AI-generated hypotheses rather than exploratory screening.

* Sharing negative data from failed experiments has massive efficiency potential but faces strong commercial and proprietary hurdles.

* Patient-facing AI agents could streamline care navigation but must overcome fragmented data silos.

* Bridging the deployment gap requires active alignment between technological innovators and clinical practitioners.